RT Journal Article
SR Electronic
T1 LAL: A Canadian Perspective
JF PDA Journal of Pharmaceutical Science and Technology
JO PDA J Pharm Sci Technol
FD Parenteral Drug Association (PDA)
SP 186
OP 189
VO 39
IS 5
A1 Norman J. Pound
YR 1985
UL http://journal.pda.org/content/39/5/186.abstract
AB The evolution of the Limulus Amebocyte Lysate (LAL) test as a rapid, sensitive, relatively simple test for bacterial endotoxins has resulted in considerable interest in its use as a test for pyrogens in parenteral products. This presentation provides an overview of the Canadian industry, the organization of the Health Protection Branch, and the regulation of pharmaceuticals in Canada, with particular emphasis on our policies related to the LAL test.